| 1 |  LLY•CH•SW $864.81B·$976.22·+10.95% | | $864.81B | $976.22 | +10.95% | - | |
| 2 |  LLY•US•NYSE $845.77B·$966.99·-2.03% | | $845.77B | $966.99 | -2.03% | 2.4M | |
| 3 |  JNJ•US•NYSE $532.77B·$221.43·-1.42% | | $532.77B | $221.43 | -1.42% | 3.6M | |
| 4 |  ROGN•MX•MX $359.67B·$434.31·+0.00% | | $359.67B | $434.31 | +0.00% | - | |
| 5 |  ABBV•US•NYSE $356.49B·$202.78·-1.10% | | $356.49B | $202.78 | -1.10% | 3.1M | |
| 6 |  4AB•DE•XETRA $355.10B·$203.05·-0.92% | | $355.10B | $203.05 | -0.92% | 1.8K | |
| 7 |  RO•CH•SW $329.48B·$419.01·-1.39% | | $329.48B | $419.01 | -1.39% | 30.3K | |
| 8 |  ROG•CH•SW $329.38B·$411.94·-6.01% | | $329.38B | $411.94 | -6.01% | 1.1M | |
| 9 |  Roche Holding AG Participation RHHVF•US•OTCQX $329.01B·$409.40·+0.10% | | $329.01B | $409.40 | +0.10% | 26 | |
| 10 | RO ROP•CH•SW $322.74B·$410.27·-0.78% | | $322.74B | $410.27 | -0.78% | 724.1K | |
| 11 |  RHHBF•US•OTCQX $319.84B·$402.00·-1.06% | | $319.84B | $402.00 | -1.06% | 100 | |
| 12 |  ZEG•DE•XETRA $293.11B·$189.00·+0.00% | | $293.11B | $189.00 | +0.00% | - | |
| 13 |  AZNCF•US•PINK $290.60B·$188.42·+2.63% | | $290.60B | $188.42 | +2.63% | 2.8M | |
| 14 |  AZN•US•NASDAQ $283.47B·$181.86·-1.65% | | $283.47B | $181.86 | -1.65% | 2.0M | |
| 15 |  AZN•SE•ST $283.05B·$184.63·-0.35% | | $283.05B | $184.63 | -0.35% | 225.9K | |
| 16 |  NVSEF•US•PINK $281.92B·$141.63·-4.14% | | $281.92B | $141.63 | -4.14% | 491 | |
| 17 |  NVS•US•NYSE $278.64B·$145.23·-2.11% | | $278.64B | $145.23 | -2.11% | 2.0M | |
| 18 |  NOVN•CH•SW $277.84B·$146.05·-1.68% | | $277.84B | $146.05 | -1.68% | 2.2M | |
| 19 | MR MRK•AT•VI $276.76B·$113.13·-0.64% | | $276.76B | $113.13 | -0.64% | 245 | |
| 20 |  MRK•US•NYSE $275.09B·$111.28·-2.01% | | $275.09B | $111.28 | -2.01% | 7.7M | |
| 21 | NO NOV•DE•XETRA $201.66B·$46.88·+1.32% | | $201.66B | $46.88 | +1.32% | 314.0K | |
| 22 |  NOVO-B•DK•CO $197.47B·$47.22·+2.39% | | $197.47B | $47.22 | +2.39% | 7.3M | |
| 23 | AM AMGN•US•NASDAQ $179.12B·$329.59·-0.46% | | $179.12B | $329.59 | -0.46% | 1.9M | |
| 24 | AM AMG•DE•XETRA $177.60B·$330.78·-0.12% | | $177.60B | $330.78 | -0.12% | 2.1K | |
| 25 |  GIS•DE•XETRA $162.05B·$133.96·-0.68% | | $162.05B | $133.96 | -0.68% | 564 | |
| 26 |  Bristol-Myers Squibb Company BRM•DE•XETRA $114.76B·$55.94·-1.67% | | $114.76B | $55.94 | -1.67% | 918 | |
| 27 |  Bristol-Myers Squibb Company BMY•US•NYSE $113.68B·$55.67·-1.63% | | $113.68B | $55.67 | -1.63% | 8.4M | |
| 28 |  SNYN•MX•MX $113.11B·$49.02·+4.32% | | $113.11B | $49.02 | +4.32% | 15 | |
| 29 |  SNW•DE•XETRA $103.75B·$86.14·-2.07% | | $103.75B | $86.14 | -2.07% | 15.3K | |
| 30 |  SAN•FR•PA $103.43B·$86.11·-1.90% | | $103.43B | $86.11 | -1.90% | 2.3M | |
| 31 |  GLAXF•US•PINK $101.42B·$24.50·-3.01% | | $101.42B | $24.50 | -3.01% | 4 | |
| 32 | GS GS71•DE•XETRA $100.63B·$25.11·-1.48% | | $100.63B | $25.11 | -1.48% | 35.9K | |
| 33 |  CHUGAI PHARMACEUTICAL CO.,LTD. 4519•JP $88.85B·$50.73·-3.54% | | $88.85B | $50.73 | -3.54% | 3.0M | |
| 34 |  Chugai Pharmaceutical Co Ltd ADR CHGCY•US•PINK $83.67B·$25.34·-6.08% | | $83.67B | $25.34 | -6.08% | 5.7K | |
| 35 |  Chugai Pharmaceutical Co. Ltd CHGCF•US•PINK $83.45B·$50.47·-8.06% | | $83.45B | $50.47 | -8.06% | 5.6K | |
| 36 | BA BAYZF•US•OTCQX $44.00B·$44.79·+0.84% | | $44.00B | $44.79 | +0.84% | - | |
| 37 |  BAYN•DE•XETRA $42.73B·$43.61·-3.71% | | $42.73B | $43.61 | -3.71% | 1.8M | |
| 38 | BA BAYRY•US•OTCQX $42.68B·$10.88·-3.20% | | $42.68B | $10.88 | -3.20% | 517.5K | |
| 39 |  DAIICHI SANKYO COMPANY,LIMITED 4568•JP $35.94B·$16.90·+1.24% | | $35.94B | $16.90 | +1.24% | 11.5M | |
| 40 | DS Daiichi Sankyo Company Limited DSKYF•US•PINK $33.56B·$17.20·+2.84% | | $33.56B | $17.20 | +2.84% | 2.0K | |
| 41 |  Daiichi Sankyo Co Ltd ADR DSNKY•US•PINK $32.62B·$17.05·+0.71% | | $32.62B | $17.05 | +0.71% | 76.6K | |
| 42 | OT OTSKF•US•PINK $32.42B·$64.57·+0.00% | | $32.42B | $64.57 | +0.00% | - | |
| 43 | 45 4578•JP $30.68B·$70.11·-2.05% | | $30.68B | $70.11 | -2.05% | 1.0M | |
| 44 |  ALPMF•US•PINK $28.82B·$15.75·+17.10% | | $28.82B | $15.75 | +17.10% | - | |
| 45 |  IDP•DE•XETRA $28.51B·$198.53·+4.66% | | $28.51B | $198.53 | +4.66% | 137 | |
| 46 |  BIIB•US•NASDAQ $26.89B·$197.95·+3.81% | | $26.89B | $197.95 | +3.81% | 1.5M | |
| 47 | AL ALPMY•US•PINK $26.50B·$14.78·+2.92% | | $26.50B | $14.78 | +2.92% | 1.7K | |
| 48 |  4503•JP $25.13B·$14.83·+5.35% | | $25.13B | $14.83 | +5.35% | 6.3M | |
| 49 | CH CSPC Pharmaceutical Group Ltd CHJTF•US•PINK $17.17B·$1.05·+0.00% | | $17.17B | $1.05 | +0.00% | - | |
| 50 | 60 Zhangzhou Pientzehuang Pharmaceutical Co Ltd 600436•CN•SHG $12.52B·$20.72·-0.28% | | $12.52B | $20.72 | -0.28% | 3.3M | |